In Brief: InStent
This article was originally published in The Gray Sheet
Executive Summary
InStent: Receives conditional approval of an investigational device exemption to begin human clinical trials of its self-expanding, nitinol CardioCoil coronary stent in reducing restenosis following angioplasty. "Conditions set forth in the approval letter from the FDA will be addressed by the company in the very near future," the firm says...